Metastatic Merkel Cell Carcinoma
Also known as: Metastatic Merkel Cell Carcinoma (MCC)
Drug | Drug Name | Drug Description |
---|---|---|
DB11945 | Avelumab | An anti-PD-L1 monoclonal antibody used to treat metastatic merkel cell carcinoma, metastatic urothelial carcinoma, or renal cell carcinoma. |
DB09037 | Pembrolizumab | A PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB11945 | Avelumab | Programmed cell death 1 ligand 1 | target |
DB09037 | Pembrolizumab | Programmed cell death protein 1 | target |
DB09037 | Pembrolizumab | Programmed cell death 1 ligand 1 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB14681 | Cortisone | 1 | Active Not Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
DB06186 | Ipilimumab | 1 | Active Not Recruiting | 1 |
DB00959 | Methylprednisolone | 1 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
DB00635 | Prednisone | 1 | Active Not Recruiting | 1 |
DB00020 | Sargramostim | 1 | Recruiting | 1 |
DB00864 | Tacrolimus | 1 | Active Not Recruiting | 1 |
DB11945 | Avelumab | 1 / 2 | Recruiting | 1 |
DB14681 | Cortisone | 1 / 2 | Recruiting | 1 |
DB06186 | Ipilimumab | 1 / 2 | Recruiting | 1 |
DB00959 | Methylprednisolone | 1 / 2 | Recruiting | 1 |
DB09035 | Nivolumab | 1 / 2 | Recruiting | 1 |
DB00635 | Prednisone | 1 / 2 | Recruiting | 1 |
DB00877 | Sirolimus | 1 / 2 | Recruiting | 1 |
DB11945 | Avelumab | 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
DB15766 | Retifanlimab | 2 | Active Not Recruiting | 1 |
DB11945 | Avelumab | Not Available | Approved for Marketing | 1 |